From the partnership with Hamburg, the Municipality of Groningen has been asked to participate in a “Life Science Learning Expedition” from 3 to 6 June to Occitania (South of France) together with our regional companies. The Occitian region has developed into a progressive player in the field of Life Science.
The purpose of the trip is to deepen our knowledge of the life sciences in the region, explore market opportunities, and further strengthen collaboration with Hamburg and its partners toward the future. The program is being developed and facilitated by the Hamburg Ministry of Economy and Innovation, the Life Science Nord Hamburg Cluster, and the Southern French economic development agency ADOCC.
Travel and accommodation costs are the responsibility of the participants. The expected costs range between €1,000 and €1,500 per person. The Municipality of Groningen can provide support with advice on flights and hotels (where the group will stay). On-site transport and program costs will be facilitated by Hamburg and Groningen.
The draft program and additional information about the Health Care region of Occitanie can be found here. A limited number of spots are available; registration is open until April 26, 2024, by sending an email to Andreas.Ensing@Groningen.nl.
If you would like to connect with life science companies that are not included in the program, please let us know. Through our partners, we will explore the possibilities of facilitating introductions.
Who is developing the most impactful innovation in Life Sciences & Health in the Northern Netherlands? Five companies are in the running for the LIFE Science Innovation Award 2026: Flux Robotics, Limosa Immunodiagnostics, SPCTR, MimeCure and GlycanScan International. The nominees will present their innovations on Tuesday 22 September during the fifth edition of the LIFE Science Conference in Groningen. An independent jury will select the winner, who will receive a €10,000 cash prize.
ZonMw is expected to open the final call for proposals within the PharmaNL Shared Development Infrastructure (SDI) program line. This program line focuses on strengthening the infrastructure for the development, upscaling, and production of innovative medicines in the Netherlands.
As the largest medical sterilization centre in the Benelux, SteriNoord B.V. provides safe, reliable, and high-quality reprocessing of medical instruments. With state-of-the-art technology and a team of dedicated professionals, the organisation plays an essential role in supporting high-quality healthcare.
